- Home
- MEDP vs CAVA Comparison
MEDP vs CAVA Comparison
Compare MEDP & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- CAVA
- Stock Information
- Founded
- MEDP 1992
- CAVA 2006
- Country
- MEDP United States
- CAVA United States
- Employees
- MEDP N/A
- CAVA N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- CAVA Restaurants
- Sector
- MEDP Health Care
- CAVA Consumer Discretionary
- Exchange
- MEDP Nasdaq
- CAVA Nasdaq
- Market Cap
- MEDP 8.5B
- CAVA 9.0B
- IPO Year
- MEDP 2016
- CAVA 2023
- Fundamental
- Price
- MEDP $309.36
- CAVA $74.62
- Analyst Decision
- MEDP Hold
- CAVA Buy
- Analyst Count
- MEDP 10
- CAVA 14
- Target Price
- MEDP $343.22
- CAVA $118.07
- AVG Volume (30 Days)
- MEDP 344.5K
- CAVA 3.5M
- Earning Date
- MEDP 07-21-2025
- CAVA 05-15-2025
- Dividend Yield
- MEDP N/A
- CAVA N/A
- EPS Growth
- MEDP 33.36
- CAVA 274.67
- EPS
- MEDP 13.09
- CAVA 1.20
- Revenue
- MEDP $2,156,580,000.00
- CAVA $1,036,533,000.00
- Revenue This Year
- MEDP $5.64
- CAVA $26.28
- Revenue Next Year
- MEDP $3.32
- CAVA $21.53
- P/E Ratio
- MEDP $23.59
- CAVA $62.12
- Revenue Growth
- MEDP 9.87
- CAVA 32.11
- 52 Week Low
- MEDP $250.05
- CAVA $70.00
- 52 Week High
- MEDP $459.77
- CAVA $172.43
- Technical
- Relative Strength Index (RSI)
- MEDP 55.79
- CAVA 30.45
- Support Level
- MEDP $294.07
- CAVA $72.36
- Resistance Level
- MEDP $304.69
- CAVA $77.40
- Average True Range (ATR)
- MEDP 9.68
- CAVA 2.85
- MACD
- MEDP 0.72
- CAVA -0.25
- Stochastic Oscillator
- MEDP 66.62
- CAVA 20.16
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.